Poly-Dtech
Private Company
Funding information not available
Overview
Founded in 2016, Poly-Dtech is a private French biotech firm that has developed a proprietary platform based on ultra-bright lanthanide nanoparticles (Bright-Dtech™) to enhance fluorescence-based detection in life sciences. The company operates a hybrid business model, selling ready-to-use assay kits and dyes while offering custom assay development and antibody conjugation services to partners in research and diagnostics. Its technology aims to bridge the gap between rapid point-of-care tests and the quantitative performance of central laboratory assays, positioning it in the growing market for advanced biomarker detection tools.
Technology Platform
Ultra-fluorescent lanthanide-doped nanoparticles (Bright-Dtech™) for high-sensitivity, time-resolved fluorescence detection in immunoassays, enabling TR-FRET, TR-FLISA, quantitative lateral flow, and multiplex applications.
Opportunities
Risk Factors
Competitive Landscape
Poly-Dtech competes with established reagent suppliers offering traditional fluorescent dyes and immunoassay kits, as well as other companies developing alternative signal amplification technologies (e.g., other nanoparticle, enzymatic, or electrochemical methods). Its differentiation lies in the specific combination of lanthanide-based brightness, long lifetime for background rejection, and a focus on enabling quantitative results on accessible readers.